CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Cash from Financing (Quarterly): 2.729M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.729M |
| September 30, 2023 | 248.92M |
| June 30, 2023 | 1.05M |
| March 31, 2023 | 93.07M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.009M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 24.54M |
| December 31, 2021 | 95.16M |
| September 30, 2021 | 23.19M |
| June 30, 2021 | 0.106M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.085M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.007M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.282M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.167M |
| March 31, 2019 | 108.02M |
| December 31, 2018 | 0.024M |
| September 30, 2018 | 1.539M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.198M |
| March 31, 2018 | 138.62M |
| December 31, 2017 | 1.019M |
| September 30, 2017 | 90.87M |
| June 30, 2017 | -0.775M |
| March 31, 2017 | 8.605M |
| December 31, 2016 | -0.742M |
| September 30, 2016 | -0.244M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 26.60M |
| June 30, 2015 | -0.384M |
| March 31, 2015 | 4.315M |
| December 31, 2014 | -0.196M |
| September 30, 2014 | 23.03M |
| June 30, 2014 | 0.003M |
| March 31, 2014 | 2.402M |
| December 31, 2013 | 2.539M |
| September 30, 2013 | 28.82M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.167M
Minimum
Jun 2019
248.92M
Maximum
Sep 2023
25.74M
Average
0.085M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Gilead Sciences Inc | -1.361B |
| Assure Holdings Corp | -0.177M |
| Societal CDMO Inc (DELISTED) | -0.854M |
| AN2 Therapeutics Inc | 0.349M |
| Madrigal Pharmaceuticals Inc | 573.71M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.38M |
| Cash from Investing (Quarterly) | -42.11M |
| Free Cash Flow | -72.98M |
| Free Cash Flow Per Share (Quarterly) | -0.2318 |
| Free Cash Flow to Equity (Quarterly) | -32.64M |
| Free Cash Flow Yield | -2.12% |